| Literature DB >> 31287842 |
Milad Azami, Mohammad Hossein YektaKooshali, Masoumeh Shohani, Ali Khorshidi, Leily Mahmudi.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0214738.].Entities:
Year: 2019 PMID: 31287842 PMCID: PMC6615610 DOI: 10.1371/journal.pone.0219466
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
MS prevalence based on region, gender, provinces, year of study and design.
| Variable | Studies (N)* | Sample (N) | Heterogeneity | 95% CI | Pooled | |||
|---|---|---|---|---|---|---|---|---|
| MS | All | I2 | P-Value | |||||
| Region | 12 different | 1 | 19524 | 46695319 | - | - | 41.2–42.4 | 42.4 |
| All Iran | 2 | 51962 | 145645451 | 99.97 | < 0.001 | 20.4–57.4 | 34.2 | |
| Center | 47 | 174229 | 368149059 | 99.94 | < 0.001 | 28.6–43.1 | 35.1 | |
| East | 8 | 3756 | 24011421 | 99.62 | < 0.001 | 5.3–18.1 | 9.8 | |
| North | 14 | 11640 | 32250226 | 99.50 | < 0.001 | 18.7–32.0 | 24.5 | |
| South | 13 | 17466 | 40504544 | 99.69 | < 0.001 | 25.6–44.6 | 33.8 | |
| West | 7 | 4237 | 12534786 | 98.01 | < 0.001 | 22.4–41.9 | 30.6 | |
| Test for subgroup differences: Q = 45.66, df(Q) = 6, P< 0.001 | ||||||||
| Gender | Male | 31 | 25711 | 76907082 | 94.77 | <0.0001 | 13.3–20.5 | 16.5 |
| Female | 31 | 74356 | 75432131 | 99.87 | < 0.001 | 36.2–55.4 | 44.8 | |
| Rate ratio of female to male: OR = 3.01 (2.79–2 = 3.24, P<0.001) | ||||||||
| Province | 12 different major provinces of Iran | 1 | 19524 | 46695319 | - | - | 41.2–42.4 | 41.8 |
| Alborz | 1 | 1737 | 2412513 | - | - | 68.7–75.5 | 72.0 | |
| All Iran | 2 | 51962 | 145645451 | 99.97 | < 0.001 | 20.4–57.4 | 34.2 | |
| Ardabil | 1 | 506 | 1248488 | - | - | 37.1–44.2 | 40.5 | |
| Bushehr | 1 | 33 | 103949 | - | - | 22.6–44.7 | 31.7 | |
| Chahar Mahaal and Bakhtiari | 1 | 537 | 895263 | - | - | 55.1–65.3 | 60.0 | |
| East Azerbaijan | 4 | 6971 | 1508315 | 99.74 | < 0.001 | 25.8–67.4 | 41.7 | |
| Fars | 4 | 11867 | 18441692 | 99.12 | < 0.001 | 52.3–76.9 | 63.4 | |
| Golestan | 1 | 373 | 1777014 | - | - | 19.0–23.2 | 21.0 | |
| Guilan | 2 | 1643 | 4961748 | 97.19 | < 0.001 | 24.5–43.9 | 32.8 | |
| Hamadan | 1 | 985 | 1758268 | - | - | 52.6–59.6 | 56.0 | |
| Hormozgan | 1 | 300 | 1578183 | - | - | 17.0–21.3 | 19.0 | |
| Ilam | 1 | 162 | 557599 | - | - | 24.9–33.9 | 29.1 | |
| Isfahan | 7 | 21302 | 32559015 | 99.79 | < 0.001 | 43.5–79.3 | 58.7 | |
| Kerman | 3 | 2102 | 6085168 | 85.39 | < 0.001 | 31.0–40.4 | 35.4 | |
| Kermanshah | 2 | 818 | 3890454 | 86.51 | < 0.001 | 17.4–25.3 | 21.0 | |
| Khuzestan | 4 | 3164 | 14295552 | 98.11 | < 0.001 | 15.3–26.2 | 20.1 | |
| Kohgiluyeh and Boyer-Ahmad | 3 | 1163 | 2030302 | 96.72 | < 0.001 | 40.3–76.8 | 55.7 | |
| Kordestan | 1 | 612 | 1493645 | - | - | 37.9–44.4 | 41.0 | |
| Lorestan | 1 | 351 | 1754244 | - | - | 18.0–22.2 | 20.0 | |
| Markazi | 1 | 862 | 1413959 | - | - | 57.0–65.2 | 61.0 | |
| Mazandaran | 2 | 1781 | 5996375 | 99.43 | < 0.001 | 14.4–53.9 | 27.9 | |
| North Khorasan | 3 | 332 | 2547026 | 92.70 | < 0.001 | 8.3–18.8 | 12.5 | |
| Qazvin | 1 | 192 | 1201565 | - | - | 13.9–18.4 | 16.0 | |
| Qom | 2 | 1180 | 2303344 | 0 | 0.60 | 4.03–44.9 | 42.5 | |
| Razavi Khorasan | 2 | 2879 | 11587481 | 99.82 | < 0.001 | 7.9–59.0 | 21.6 | |
| Semnan | 1 | 353 | 631218 | - | - | 50.4–62.1 | 55.9 | |
| Sistan and Balouchestan | 5 | 771 | 11761406 | 75.34 | < 0.001 | 5.6–7.5 | 6.5 | |
| South Khorasan | 2 | 140 | 1298954 | 99.77 | < 0.001 | 3.2–27.3 | 9.3 | |
| Tehran | 28 | 146270 | 322611718 | 99.96 | < 0.001 | 20.7–36.7 | 27.6 | |
| West Azerbaijan | 1 | 1309 | 3080576 | - | - | 4.03–44.9 | 42.5 | |
| Yazd | 1 | 440 | 1074428 | - | - | 37.3–45.0 | 41.0 | |
| Zanjan | 1 | 193 | 1015734 | - | - | 16.5–21.9 | 19.0 | |
| Test for subgroup differences: Q = 2559.92, df(Q) = 32, P< 0.001 | ||||||||
| Year of study | < 1990 | 2 | 1110 | 17539552 | 69.13 | 0.072 | 5.7–7.0 | 6.3 |
| 1990–1994 | 5 | 4382 | 47222144 | 97.14 | < 0.001 | 7.6–10.8 | 9.1 | |
| 1995–1999 | 5 | 9763 | 53251981 | 98.62 | < 0.001 | 15.1–21.3 | 17.9 | |
| 2000–2004 | 5 | 20412 | 60955029 | 99.27 | < 0.001 | 27.9–38.6 | 32.8 | |
| 2005–2009 | 20 | 58545 | 182277428 | 99.82 | < 0.001 | 15.5–23.6 | 19.1 | |
| 2010–2014 | 51 | 151690 | 280165726 | 99.81 | < 0.001 | 35.8–45.8 | 40.5 | |
| 2015–2018 | 4 | 36912 | 28378946 | 99.76 | < 0.001 | 50.7–85.0 | 65.6 | |
| Test for subgroup differences: Q = 744.07, df(Q) = 6, P< 0.001 | ||||||||
| Study design | Population based | 82 | 266175 | 627821102 | 99.83 | < 0.001 | 27.0–35.9 | 31.1 |
| Cross-sectional | 10 | 16639 | 41969704 | 99.92 | < 0.001 | 11.7–27.3 | 17.9 | |
| Test for subgroup differences: Q = 5.89, df(Q) = 1, P = 0.015 | ||||||||
N: Number; CI: confidence interval
* Some studies have been included and estimated the prevalence and incidence for more than 1 year and also regions. Each data was considered separately because of assessing the slope of prevalence and incidence in the years and estimating which region is the highest or lowest